IGF-1LR3

IGF-1 LR3 (Long Arginine3 Insulin-like Growth Factor 1) is a modified synthetic analogue of naturally occurring IGF-1. Specifically, it is engineered with an additional 13-amino-acid N-terminal extension and a glutamic acid-to-arginine substitution at position 3. igf-1lr3 peptide

In contrast to endogenous IGF-1, these specific structural modifications significantly reduce its affinity for inhibitory IGF-binding proteins (IGFBPs). Mechanistically, this lack of binding protein sequestration leaves a far higher fraction of free peptide active, resulting in extended bioavailability and a substantially prolonged metabolic half-life in research models. igf-1lr3 peptide

Consequently, studies have investigated its heightened capacity to activate the cell-surface IGF-1 receptor (IGF-1R) signaling cascade—a principal pathway governing cell proliferation, differentiation, and protein synthesis. In addition, researchers have examined its unique ability to stimulate muscular hyperplasia (the formation of new muscle cells) alongside classic hypertrophic growth in existing fibers. Furthermore, in vitro experiments demonstrate that IGF-1 LR3 potently modulates insulin receptor crosstalk, enhancing glucose and amino acid uptake in cultured cell lines. Overall, as a hyper-potent variant of a key endocrine growth factor, IGF-1 LR3 remains an essential research tool for exploring muscle physiology, metabolic signaling, and regenerative cellular processes.